chenodeoxycholic acid has been researched along with Cholangitis, Sclerosing in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, AH; Atkinson, EJ; Eaton, JE; Hu, C; Iyer, RK; Juran, BD; Lazaridis, KN; McCauley, BM | 1 |
| Ahn, DW | 1 |
| Trauner, M | 1 |
| Andreone, P; Gitto, S; Guarneri, V; Sartini, A | 1 |
| Goldstein, J; Levy, C | 1 |
| Carey, EJ; Yokoda, RT | 1 |
| Vetter, C | 1 |
| Beuers, U; de Vries, EM; de Waart, DR; Groen, AK; Jansen, PL; Koelfat, KV; Lenicek, M; Olde Damink, SW; Ponsioen, C; Schaap, FG; Tolenaars, D; Zweers, SJ | 1 |
| Beuers, U; de Vries, E | 1 |
| Cheung, AC; Gores, GJ; LaRusso, NF; Lazaridis, KN | 1 |
| Li, B; Ma, X; Wang, QX | 1 |
| Befeler, AS; Eaton, JE; Harnois, D; Harrison, ME; Jorgensen, R; Kowdley, KV; Lindor, KD; Luketic, VA; McCashland, T; Pardi, DS; Petz, J; Silveira, MG; Sinakos, E | 1 |
| Endele, R; Rudolph, G; Senn, M; Stiehl, A | 1 |
| Azer, SA; Byth, K; Coverdale, SA; Farrell, GC; Stacey, NH | 1 |
| Salemans, JM; Tangerman, A; Van Berge-Henegouwen, GP; van Buuren, HR; van de Meeberg, PC; van Erpecum, KJ; van Hattum, J; Wolfhagen, FH | 1 |
| Aydemir, U; Beuers, U; Heldwein, W; Kruis, W; Pape, GR; Paumgartner, G; Sauerbruch, T; Spengler, U; Weinzierl, M; Wiebecke, B | 1 |
7 review(s) available for chenodeoxycholic acid and Cholangitis, Sclerosing
| Article | Year |
|---|---|
[Novel Insights of Primary Sclerosing Cholangitis and Primary Biliary Cholangitis].
Topics: Alkaline Phosphatase; Chenodeoxycholic Acid; Cholangitis, Sclerosing; Humans; Liver Cirrhosis, Biliary; Prognosis; Risk Factors; Ursodeoxycholic Acid | 2020 |
The use of obeticholic acid for the management of non-viral liver disease: current clinical practice and future perspectives.
Topics: Animals; Chenodeoxycholic Acid; Cholangitis, Sclerosing; Disease Models, Animal; Humans; Hypertension, Portal; Liver; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Treatment Outcome | 2018 |
Novel and emerging therapies for cholestatic liver diseases.
Topics: Bile Acids and Salts; Budesonide; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis; Drug Therapy, Combination; Elasticity Imaging Techniques; Humans; Immunosuppressive Agents; Liver; Liver Cirrhosis, Biliary; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid | 2018 |
Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.
Topics: Adult; Biliary Tract; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis; Clinical Trials as Topic; Disease Progression; Drug Therapy, Combination; End Stage Liver Disease; Humans; Immunologic Factors; Life Expectancy; Prevalence; Prognosis; Treatment Outcome; Ursodeoxycholic Acid | 2019 |
Management of cholestatic disease in 2017.
Topics: Bile Acids and Salts; Bile Ducts; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis, Sclerosing; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid | 2017 |
Emerging pharmacologic therapies for primary sclerosing cholangitis.
Topics: Anti-Bacterial Agents; Chenodeoxycholic Acid; Cholangitis, Sclerosing; Clinical Trials as Topic; Fecal Microbiota Transplantation; Fibric Acids; Gastrointestinal Microbiome; Humans; Immunologic Factors; Molecular Targeted Therapy; Organic Anion Transporters, Sodium-Dependent; Probiotics; Symporters; Ursodeoxycholic Acid | 2017 |
[Research advances in autoimmune liver diseases in 2016].
Topics: Autoimmune Diseases; Biomedical Research; Chenodeoxycholic Acid; Cholangitis; Cholangitis, Sclerosing; Clinical Trials, Phase III as Topic; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Liver Diseases | 2017 |
4 trial(s) available for chenodeoxycholic acid and Cholangitis, Sclerosing
| Article | Year |
|---|---|
High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
Topics: Adolescent; Adult; Aged; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis, Sclerosing; Colitis, Ulcerative; Colorectal Neoplasms; Female; Follow-Up Studies; Humans; Lithocholic Acid; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Risk; Ursodeoxycholic Acid; Young Adult | 2011 |
Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease.
Topics: Adult; Aged; Bile Acids and Salts; Chenodeoxycholic Acid; Cholangitis, Sclerosing; Cholestasis; Cholic Acid; Cholic Acids; Chromatography, High Pressure Liquid; Chronic Disease; Female; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Male; Middle Aged; Predictive Value of Tests; Prognosis; Survival Rate | 1996 |
Single or multiple dose ursodeoxycholic acid for cholestatic liver disease: biliary enrichment and biochemical response.
Topics: Adult; Alkaline Phosphatase; Bile Acids and Salts; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis, Sclerosing; Chromatography, Gas; Cross-Over Studies; Deoxycholic Acid; Dose-Response Relationship, Drug; Female; Follow-Up Studies; gamma-Glutamyltransferase; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Regression Analysis; Transaminases; Treatment Outcome; Ursodeoxycholic Acid | 1996 |
Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial.
Topics: Adolescent; Adult; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Chenodeoxycholic Acid; Cholangitis, Sclerosing; Cholic Acid; Cholic Acids; Deoxycholic Acid; Diarrhea; Double-Blind Method; Female; Humans; Liver; Male; Middle Aged; Prospective Studies; Ursodeoxycholic Acid | 1992 |
5 other study(ies) available for chenodeoxycholic acid and Cholangitis, Sclerosing
| Article | Year |
|---|---|
Predicting cholangiocarcinoma in primary sclerosing cholangitis: using artificial intelligence, clinical and laboratory data.
Topics: Artificial Intelligence; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Chenodeoxycholic Acid; Cholangiocarcinoma; Cholangitis, Sclerosing; Humans; Inflammatory Bowel Diseases; Sexually Transmitted Diseases | 2023 |
Effective medical treatments for PSC needed ASAP - is AESOP the answer?
Topics: Chenodeoxycholic Acid; Cholangitis, Sclerosing; Humans | 2020 |
[In Process Citation].
Topics: Chenodeoxycholic Acid; Cholangitis, Sclerosing; Hope; Humans; Life Expectancy; Liver Cirrhosis, Biliary; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid | 2015 |
Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge.
Topics: Administration, Oral; Adult; Aged; Case-Control Studies; Cathartics; Chenodeoxycholic Acid; Cholangitis, Sclerosing; Cholestenones; Clinical Protocols; Female; Fibroblast Growth Factors; Humans; Intestinal Mucosa; Liver; Male; Middle Aged | 2017 |
Effect of ursodeoxycholic acid on the kinetics of cholic acid and chenodeoxycholic acid in patients with primary sclerosing cholangitis.
Topics: Adult; Chenodeoxycholic Acid; Cholangitis, Sclerosing; Cholic Acid; Cholic Acids; Colitis, Ulcerative; Humans; Kinetics; Male; Middle Aged; Ursodeoxycholic Acid | 1993 |